CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
9.96
-0.37 (-3.58%)
At close: Nov 22, 2024, 4:00 PM
9.94
-0.02 (-0.20%)
After-hours: Nov 22, 2024, 6:50 PM EST
CorMedix Revenue
CorMedix had revenue of $11.46M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $12.26M, up 41,184.20% year-over-year.
Revenue (ttm)
$12.26M
Revenue Growth
+41,184.20%
P/S Ratio
46.99
Revenue / Employee
$147,738
Employees
83
Market Cap
604.34M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | 65.41K | -125.53K | -65.74% |
Dec 31, 2021 | 190.94K | -48.30K | -20.19% |
Dec 31, 2020 | 239.23K | -44.04K | -15.55% |
Dec 31, 2019 | 283.27K | -146.53K | -34.09% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
agilon health | 5.59B |
Varex Imaging | 811.00M |
InnovAge Holding | 786.51M |
Definitive Healthcare | 255.85M |
Entrada Therapeutics | 215.23M |
Adaptive Biotechnologies | 177.28M |
IRADIMED CORPORATION | 71.31M |
Arbutus Biopharma | 6.74M |
CRMD News
- 15 days ago - Stock Picks From Seeking Alpha's October 2024 New Analysts - Seeking Alpha
- 19 days ago - CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium - GlobeNewsWire
- 24 days ago - CorMedix Inc. (CRMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 26 days ago - CorMedix 2.0: New Leadership, New Approval, New Focus - Seeking Alpha
- 4 weeks ago - Undercovered Dozen: CorMedix, Cabaletta, Skyx Platforms, Dynex Capital + - Seeking Alpha
- 4 weeks ago - CorMedix Inc. Announces New Data at ASN Kidney Week 2024 - GlobeNewsWire
- 4 weeks ago - CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024 - GlobeNewsWire